Jesper’s charge is to ensure the LEO Foundation’s active ownership of LEO Pharma, management of the Foundation’s financial assets, and to enhance the Foundation’s standing with the global scientific research community through donations to promising and groundbreaking research and relevant educational activities in dermatology in particular and lifescience in general.
His background includes top management positions in innovative Danish companies: President & CEO for Alectia A/S, RTX A/S and GN Resound A/S as well as Executive Vice President, GN Great Nordic A/S. Prior, he worked as Senior Vice President, Sales & Marketing for Nycomed Pharma (now Takeda) and as associate with McKinsey & Company. He holds an MBA from Insead and a BSc in economics from Copenhagen Business School.
Other management positions
Etac Group, Non-executive Director of the Board
Sonion, Non-executive Director of the Board
RTX A/S, Non-executive Director of the Board
Charlotte’s responsibilities include administrative coordination in the Foundation including preparation and follow-up tasks for the Board of Trustees and assisting the CEO in coordinating and implementing the Foundation’s activities as well as ad hoc- and cross-organisational tasks.
Charlotte has previously worked for a.o. CGI Group, Rockwool International A/S and Anritsu A/S.
Arne’s main responsibility is to curate the rich LEO history through careful tending to the LEO Museum & Archives. This includes ongoing collaborations with historians and scholars using the well-documented historical archives for research purposes, liaison to other historical pharmaceutical collections as well as tasks related to archiving.
Arne has previously worked for LEO Pharma A/S and the University Library of Copenhagen.